[Marketwire] - Medivation, Inc. and Astellas Pharma Inc. today announced that the companies have established an updated interim analysis plan for the PREVAIL trial, a global Phase 3 clinical trial evaluating XTANDI® ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment